Skip to content
Research Article Open access CC BY 4.0

In-vivo Study on Organometallic Compounds as Anticancer Agents

F. Z. Mohammed, Elsherbiny H. Elsayed, Atef E. Abd Elbaky, H. M. Shalaby

Asian Journal of Research in Biochemistry · pp. 1–8 · Published 2 Aug 2019

10.9734/ajrb/2019/v5i130082

Abstract

This study aims to study the in-vivo anticancer effect of the synthesized copper complexes of 2,3-dihydroxy benzaldehyde thiosemicarbazone (3a,b), followed by evaluating their antioxidant activity.  Materials and methods: A total number of 80 adult female swiss albino mice weighing 20-25 gm were divided into 8 groups (10 mice /each group).  The acute toxicity was estimated by intraperitoneal injection of the compounds (3a, b). Results:  We found that, 5 mg /kg and 10 mg /kg were considered to be the most effective dose of compounds 3a & 3b, respectively. The mean volume of EAC in the positive control group was found to be 4.2 ±0.5 (mL), this value was significantly decreased by 100%, (p<0.001) for 3a & 3b treated groups, respectively.

Anticancer copper complexes 2,3-dihydroxy benzaldehyde thiosemicarbazone Erhlich Ascites Carcinoma (EAC) swiss albino mice.

Cited by 1

In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent

Faten Z. Mohammed, Youstina W. Rizzk, Moustafa S. Abdelhamid · Anti-Cancer Agents in Medicinal Chemistry · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.